Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.
Comparison: Wegovy vs Zepbound
Both items are reviewed at GLP1 One Rx against the v3.0 transparency rubric and published clinical evidence.
Key differentiators
- Active ingredient: Wegovy is semaglutide (Novo Nordisk); Zepbound is tirzepatide (Eli Lilly).
- Mechanism: Wegovy GLP-1; Zepbound dual GLP-1/GIP.
- Weight loss: tirzepatide trended higher in SURPASS-2 (vs semaglutide 1 mg).
- CV indication: Wegovy has FDA-approved CV risk reduction; Zepbound has FDA-approved OSA indication.